跳至主要内容
临床试验/NCT01696825
NCT01696825终止1 期

COMPARISON OF ABSORPTION OF VAGINAL DIAZEPAM USING DIFFERENT DELIVERY SYSTEMS

Jason Gilleran1 个研究点 分布在 1 个国家目标入组 3 人开始时间: 2012年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
终止
发起方
入组人数
3
试验地点
1
主要终点
Serum diazepam levels measured over time

研究概览

简要总结

The purpose of this study is to determine which of three delivery systems of vaginal diazepam have the best systemic absorption, measured by serum diazepam levels. The three delivery systems are: moistened tablet, suppository or cream. Additionally the study will compare the side effects and absorption of vaginal diazepam with oral diazepam. Vaginal diazepam is used off-label vaginally to relax pelvic floor muscles and reduce pelvic pain caused from pelvic floor dysfunction.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Provide informed consent
  • Premenopausal women > age 18
  • Able to provide urine and serum samples during the time period

排除标准

  • Current use of benzodiazepines in any form. If history of benzodiazepine use, must not have taken for one week prior to study screening and enrollment
  • Pregnancy
  • Concomitant use of any narcotic drug, ethanol, or any illicit drug use during the study period that could be deemed unsafe in combination with benzodiazepine medication use as judged by the investigators.
  • Any evidence of vaginitis on wet mount slide
  • Postmenopausal
  • Subject with any other vaginal epithelial disorder that could affect absorption of medication as deemed by the investigators.
  • Any indication/condition/medication that the investigators identify as contraindicated in conjunction with diazepam.

研究组 & 干预措施

Diazepam Tablet, 5 mg, Vaginal

Experimental

干预措施: Diazepam tablet, 5 mg, vaginal (Drug)

Diazepam Suppository, 5 mg, Vaginal

Experimental

干预措施: Diazepam Suppository, 5 mg, vaginal (Drug)

Diazepam Cream, 5 mg, Vaginal

Experimental

干预措施: Diazepam Cream, 5 mg, Vaginal (Drug)

Diazepam Tablet, 5 Mg, Oral

Active Comparator

干预措施: Diazepam tablet, 5 mg, vaginal (Drug)

Diazepam Tablet, 5 Mg, Oral

Active Comparator

干预措施: Diazepam Suppository, 5 mg, vaginal (Drug)

Diazepam Tablet, 5 Mg, Oral

Active Comparator

干预措施: Diazepam Cream, 5 mg, Vaginal (Drug)

结局指标

主要结局

Serum diazepam levels measured over time

时间窗: Baseline then 2 hours, 4 hours and 8 hours post-medication administration

次要结局

  • Side effects observed with each of three types of vaginal diazepam(Baseline and 2 hours, 4 hours and 8 hours post medication administration)

研究者

发起方
Jason Gilleran
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Jason Gilleran

Physician

William Beaumont Hospitals

研究点 (1)

Loading locations...

相似试验

Comparison of Absorption of Vaginal Diazepam Using... | 临床试验